News

Filter By

2018/12/13

WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange

HONG KONG and SHANGHAI, December 12, 2018-- WuXi AppTec Co., Ltd. (“WuXi AppTec” or “the Company”; Stock code: 603259.SH/2359.HK) today announced the listing of approximately 116 million H-shares on the Main Board of the Hong Kong Stock Exchange. Based on the offer price of HK$68 per share, the net proceeds to be received by the Company are about HK$7,553 million (assuming the Over-allotment Option is not exercised).

Read more

2018/12/11

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

SAN DIEGO, CA and SHANGHAI, December 10, 2018 – WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California.

Read more

2018/11/28

WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan

SHANGHAI, Nov. 28, 2018 -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that it received the 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan, a top-notch business research and consulting firm. WuXi was awarded for the second consecutive year.

Read more

2018/11/16

WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou

WuXi AppTec announces today that its Laboratory Testing Division’s new Medical Device Testing Center opens today in Suzhou, China.

Read more

2018/10/23

China Electronics Data and WuXi AppTec Form CW Data, a Joint Venture to Offer One-Stop Healthcare Big Data Solutions

China Electronics Data Service Co., Ltd. (“CECD”) and WuXi AppTec announced today to set up a joint venture, CW Data, to offer one-stop big data solutions for the healthcare sector.

Read more